{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:02Z","timestamp":1791477902709,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Projects Unit of Inonu University","award":["TCD-2021-2359"],"award-info":[{"award-number":["TCD-2021-2359"]}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","award":["120C152"],"award-info":[{"award-number":["120C152"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06587-0","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T10:15:57Z","timestamp":1652523357000},"page":"2155-2166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolomic analysis of endometrial cancer by high-resolution magic angle spinning NMR spectroscopy"],"prefix":"10.1007","volume":"306","author":[{"given":"Senem","family":"Arda D\u00fcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u0131n","family":"Mumcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berat","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"\u0130nci \u00c7o\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdin\u00e7","family":"Sar\u0131dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6rkem","family":"Tuncay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-6211","authenticated-orcid":false,"given":"Abdullah","family":"Karaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"key":"6587_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941\u20131953","journal-title":"Int J Cancer"},{"key":"6587_CR2","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2217\/fon.14.192","volume":"10","author":"MA Sheikh","year":"2014","unstructured":"Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, Sukumvanich P, Comerci J, Kelley J, LaPorte RE, Linkov F (2014) USA endometrial cancer projections to 2030: should we be concerned? Future Oncol Lond Engl 10:2561\u20132568","journal-title":"Future Oncol Lond Engl"},{"key":"6587_CR3","first-page":"107","volume":"208","author":"E Shaw","year":"2016","unstructured":"Shaw E, Farris M, McNeil J, Friedenreich C (2016) Obesity and endometrial cancer. Obesity. Cancer 208:107\u2013136","journal-title":"Cancer"},{"issue":"6","key":"6587_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","volume":"205","author":"RE Schmandt","year":"2011","unstructured":"Schmandt RE, Iglesias DA, Co NN, Lu KH (2011) Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 205(6):518\u2013525","journal-title":"Am J Obstet Gynecol"},{"key":"6587_CR5","doi-asserted-by":"crossref","unstructured":"Nees LK, Heublein S, Steinmacher S, Juhasz-B\u00f6ss I, Brucker S, Tempfer CB, Wallwiener M (2022) Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. Jan 10. Epub ahead of print","DOI":"10.1007\/s00404-021-06380-5"},{"key":"6587_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366:491\u2013505","journal-title":"Lancet"},{"key":"6587_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.5114\/aoms.2010.19305","volume":"6","author":"L Gottwald","year":"2010","unstructured":"Gottwald L, Pluta P, Piekarski J, Spych M, Hendzel K, Topczewska-Tylinska K, Nejc D, Bibik R, Korczy\u0144ski J, Cia\u0142kowska-Rysz A (2010) Long-term survival of endometrioid endometrial cancer patients. Arch Med Sci AMS 6:937\u2013944","journal-title":"Arch Med Sci AMS"},{"key":"6587_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ajog.2005.01.018","volume":"193","author":"KI Pappa","year":"2005","unstructured":"Pappa KI, Anagnou NP (2005) Emerging issues of the expression profling technologies for the study of gynecologic cancer. Am J Obstet Gynecol 193:908\u2013918","journal-title":"Am J Obstet Gynecol"},{"key":"6587_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","volume":"20","author":"MM Rinschen","year":"2019","unstructured":"Rinschen MM, Ivanisevic J, Giera M, Siuzdak G (2019) Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol 20:353\u2013367","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6587_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1039\/C1AN15605E","volume":"137","author":"A Zhang","year":"2012","unstructured":"Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Modern analytical techniques in metabolomics analysis. Analyst 137:293\u2013300","journal-title":"Analyst"},{"key":"6587_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/metabo3030552","volume":"3","author":"RD Beger","year":"2013","unstructured":"Beger RD (2013) A review of applications of metabolomics in cancer. Metabolites 3:552\u2013574","journal-title":"Metabolites"},{"key":"6587_CR12","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00404-021-06015-9","volume":"303","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhu Y, Li X, Zhang X, Yu B (2021) Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer. Arch Gynecol Obstet 303:1599\u20131606","journal-title":"Arch Gynecol Obstet"},{"key":"6587_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2016.04.025","volume":"100","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Frezza C (2016) Oncometabolites: unconventional triggers of oncogenic signalling cascades. Free Radical Biol Med 100:175\u2013181","journal-title":"Free Radical Biol Med"},{"key":"6587_CR14","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1172\/JCI67228","volume":"123","author":"M Yang","year":"2013","unstructured":"Yang M, Soga T, Pollard PJ (2013) Oncometabolites: linking altered metabolism with cancer. J Clin Investig 123:3652\u20133658","journal-title":"J Clin Investig"},{"key":"6587_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart DS (2016) Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov 15:473\u2013484","journal-title":"Nat Rev Drug Discov"},{"key":"6587_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clinbiochem.2018.09.002","volume":"61","author":"W Wang","year":"2018","unstructured":"Wang W, Lv J, Chen N, Lou B, Mao W, Wang P, Chen Y (2018) Dysregulated serum metabolites in staging of hepatocellular carcinoma. Clin Biochem 61:7\u201311","journal-title":"Clin Biochem"},{"key":"6587_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11306-016-0990-0","volume":"12","author":"O Turkoglu","year":"2016","unstructured":"Turkoglu O, Zeb A, Graham S, Szyperski T, Szender JB, Odunsi K, Bahado-Singh R (2016) Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature. Metabolomics 12:60. https:\/\/doi.org\/10.1007\/s11306-016-0990-0","journal-title":"Metabolomics"},{"key":"6587_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/14737159.8.5.617","volume":"8","author":"GA Gowda","year":"2008","unstructured":"Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D (2008) Metabolomics based methods for early disease diagnostics. Expert Rev Mol Diagn 8:617\u2013633. https:\/\/doi.org\/10.1586\/14737159.8.5.617","journal-title":"Expert Rev Mol Diagn"},{"key":"6587_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1134\/S1061934808020020","volume":"63","author":"TN Kolokolova","year":"2008","unstructured":"Kolokolova TN, Savel\u2019ev OY, Sergeev NM (2008) Metabolic analysis of human biological fluids by 1H-NMR spectroscopy. J Analyt Chem 63:104\u2013120","journal-title":"J Analyt Chem"},{"key":"6587_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nbm.1478","volume":"23","author":"B Sitter","year":"2010","unstructured":"Sitter B, Bathen TF, Singstad TE, Fj\u00f8sne HE, Lundgren S, Halgunset J, Gribbestad IS (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed Int J Devoted Dev Appl Magnet Resonance In vivo 23:424\u2013431. https:\/\/doi.org\/10.1002\/nbm.1478","journal-title":"NMR Biomed Int J Devoted Dev Appl Magnet Resonance In vivo"},{"issue":"6","key":"6587_CR21","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/mrm.20909","volume":"55","author":"MG Swanson","year":"2006","unstructured":"Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J\u00a0(2006) Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magnet Resonance Med 55(6):1257\u20131264","journal-title":"Magnet Resonance Med"},{"issue":"1","key":"6587_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/156802611793611869","volume":"11","author":"S Moestue","year":"2011","unstructured":"Moestue S, Sitter B, Frost Bathen T, Tessem M-B, Susann GI (2011) HR MAS MR spectroscopy in metabolic characterization of cancer. Curr Top Med Chem 11(1):2\u201326","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"6587_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/metabo9020019","volume":"9","author":"M Gogiashvili","year":"2019","unstructured":"Gogiashvili M, Nowacki J, Hergenr\u00f6der R, Hengstler JG, Lambert J, Edlund K (2019) HR-MAS NMR based quantitative metabolomics in breast cancer. Metabolites 9(2):19","journal-title":"Metabolites"},{"issue":"1","key":"6587_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep03349","volume":"3","author":"M Renault","year":"2013","unstructured":"Renault M, Shintu L, Piotto M, Caldarelli S (2013) Slow-spinning low-sideband HR-MAS NMR spectroscopy: delicate analysis of biological samples. Sci Rep 3(1):1\u20135","journal-title":"Sci Rep"},{"key":"6587_CR25","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1073\/pnas.94.12.6408","volume":"94","author":"LL Cheng","year":"1997","unstructured":"Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG (1997) Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 94:6408\u20136413. https:\/\/doi.org\/10.1073\/pnas.94.12.6408","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"6587_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-97505-y","volume":"11","author":"A Skorupa","year":"2021","unstructured":"Skorupa A, Po\u0144ski M, Ciszek M, Cicho\u0144 B, Klimek M, Witek A, Paku\u0142o S, Boguszewicz \u0141, Sok\u00f3\u0142 M.\u00a0(2021) Grading of endometrial cancer using 1H HR-MAS NMR-based metabolomics. Sci Rep 11(1):1\u201317","journal-title":"Sci Rep"},{"issue":"1","key":"6587_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mrm.27696","volume":"82","author":"E Ruhland","year":"2019","unstructured":"Ruhland E, Bund C, Outilaft H, Piotto M, Namer IJ (2019) A metabolic database for biomedical studies of biopsy specimens by high-resolution magic angle spinning nuclear MR: a qualitative and quantitative tool. Magn Reson Med 82(1):62\u201383","journal-title":"Magn Reson Med"},{"issue":"W1","key":"6587_CR28","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques P\u00c9, Li S, Xia J (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49(W1):W388\u2013W396","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"6587_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3162","volume":"11","author":"K Glunde","year":"2011","unstructured":"Glunde K, Bhujwalla ZM, Ronen SM (2011) Choline metabolism in malignant transformation. Nat Rev Cancer 11(12):835\u2013848","journal-title":"Nat Rev Cancer"},{"key":"6587_CR30","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL (2017) The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr 1859:1558\u20131572","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"6587_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9258(19)50785-2","volume":"222","author":"EP Kennedy","year":"1956","unstructured":"Kennedy EP, Weiss SB (1956) The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 222:193\u2013214","journal-title":"J Biol Chem"},{"key":"6587_CR32","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1158\/0008-5472.CAN-13-2409","volume":"74","author":"S Trousil","year":"2014","unstructured":"Trousil S, Lee P, Pinato DJ, Ellis JK, Dina R, Aboagye EO, Keun HC, Sharma R (2014) Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway. Cancer Res 74:6867\u20136877. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2409","journal-title":"Cancer Res"},{"key":"6587_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.17179\/excli2019-2071","volume":"18","author":"W Albrecht","year":"2019","unstructured":"Albrecht W (2019) Highlight report: role of choline phospholipid metabolism in tumor progression. EXCLI J 18:1097\u20131098. https:\/\/doi.org\/10.17179\/excli2019-2071","journal-title":"EXCLI J"},{"key":"6587_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fonc.2016.00266","volume":"6","author":"M Cheng","year":"2016","unstructured":"Cheng M, Bhujwalla Z, Glunde K (2016) Targeting phospholipid metabolism in cancer. Front Oncol 6:266. https:\/\/doi.org\/10.3389\/fonc.2016.00266","journal-title":"Front Oncol"},{"key":"6587_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.celrep.2019.08.087","volume":"29","author":"T Osawa","year":"2019","unstructured":"Osawa T, Shimamura T, Saito K, Hasegawa Y, Ishii N, Nishida M et al (2019) Phosphoethanolamine accumulation protects cancer cells under glutamine starvation through downregulation of PCYT2. Cell Rep 29:89-103.e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.087","journal-title":"Cell Rep"},{"key":"6587_CR36","doi-asserted-by":"publisher","first-page":"e3936","DOI":"10.1002\/nbm.3936","volume":"31","author":"T Shah","year":"2018","unstructured":"Shah T, Krishnamachary B, Wildes F, Wijnen JP, Glunde K, Bhujwalla ZM (2018) Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells. NMR Biomed 31:e3936. https:\/\/doi.org\/10.1002\/nbm.3936","journal-title":"NMR Biomed"},{"key":"6587_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J (2020) Amino acids in cancer. Exp Mol Med 52:15\u201330. https:\/\/doi.org\/10.1038\/s12276-020-0375-3","journal-title":"Exp Mol Med"},{"key":"6587_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4331\/wjbc.v6.i4.281","volume":"6","author":"E Ananieva","year":"2015","unstructured":"Ananieva E (2015) Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World J Biol Chem 6:281\u2013289. https:\/\/doi.org\/10.4331\/wjbc.v6.i4.281","journal-title":"World J Biol Chem"},{"issue":"1","key":"6587_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MCO.0000000000000430","volume":"21","author":"EA Ananieva","year":"2018","unstructured":"Ananieva EA, Wilkinson AC (2018) Branched-chain amino acid metabolism in cancer. Curr Opin Clin Nutr Metab Care 21(1):64\u201370","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"6587_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10147-013-0565-2","volume":"19","author":"Y Ihata","year":"2013","unstructured":"Ihata Y, Miyagi E, Numazaki R, Muramatsu T, Imaizumi A, Yamamoto H, Yamakado M, Okamoto N, Hirahara F (2013) Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker. Int J Clin Oncol 19:364\u2013372. https:\/\/doi.org\/10.1007\/s10147-013-0565-2","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"6587_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","volume":"19","author":"C Nie","year":"2018","unstructured":"Nie C, He T, Zhang W, Zhang G, Ma X (2018) Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci 19(4):954","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6587_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun AA, Lukey MJ, Cerione RA, Locasale JW (2017) Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3(3):169\u2013180","journal-title":"Trends Cancer"},{"key":"6587_CR43","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1038\/oncsis.2017.70","volume":"6","author":"A Marshall","year":"2017","unstructured":"Marshall A, van Geldermalsen M, Otte NJ, Lum T, Vellozzi M, Thoeng A, Pang A, Nagarajah R, Zhang B, Wang Q, Anderson L, Rasko JEJ, Holst J (2017) ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis 6:e367. https:\/\/doi.org\/10.1038\/oncsis.2017.70","journal-title":"Oncogenesis"},{"key":"6587_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2020.05.383","volume":"159","author":"S Asaka","year":"2020","unstructured":"Asaka S, Yen TT, Shen YA, Hong J, Asaka R, Shih IM, Wang TL, Gaillard S (2020) Glutaminase expression is correlated with adverse clinicopathological features and patient outcome in endometrial cancer. Gynecol Oncol 159:229","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6587_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2017.178","volume":"26","author":"YK Choi","year":"2018","unstructured":"Choi YK, Park KG (2018) Targeting glutamine metabolism for cancer treatment. Biomol Ther Seoul 26(1):19\u201328","journal-title":"Biomol Ther Seoul"},{"key":"6587_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891899","journal-title":"Nat Rev Cancer"},{"key":"6587_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41:211\u2013218","journal-title":"Trends Biochem Sci"},{"key":"6587_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.26410","volume":"131","author":"AN Mendler","year":"2012","unstructured":"Mendler AN, Hu B, Prinz PU, Kreutz M, Gottfried E, Noessner E (2012) Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation. Int J Cancer 131:633\u2013640","journal-title":"Int J Cancer"},{"key":"6587_CR49","doi-asserted-by":"publisher","first-page":"38123819","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:38123819","journal-title":"Blood"},{"key":"6587_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188427","volume":"1874","author":"MM Kes","year":"2020","unstructured":"Kes MM, Van den Bossche J, Griffioen AW, Huijbers EJ (2020) Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors. Biochim Biophys Acta Rev Cancer 1874:188427","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"9","key":"6587_CR51","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/aogs.13847","volume":"99","author":"A Raffone","year":"2020","unstructured":"Raffone A, Troisi J, Boccia D, Travaglino A, Capuano G, Insabato L, Mollo A, Guida M, Zullo F (2020) Metabolomics in endometrial cancer diagnosis: a systematic review. Acta Obstet Gynecol Scand 99(9):1135\u20131146","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6587_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11306-017-1290-z","volume":"14","author":"RO Bahado-Singh","year":"2018","unstructured":"Bahado-Singh RO, Lugade A, Field J, Al-Wahab Z, Han B, Mandal R, Bjorndahl TC, Turkoglu O, Graham SF, Wishart D, Odunsi K. (2018) Metabolomic prediction of endometrial cancer. Metabolomics 14:6","journal-title":"Metabolomics"},{"key":"6587_CR53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jsbmb.2018.01.012","volume":"178","author":"T Knific","year":"2018","unstructured":"Knific T, Vouk K, Smrkolj \u0160, Prehn C, Adamski J, Ri\u017ener TL (2018) Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer. J Steroid Biochem Mol Biol 178:312\u2013321","journal-title":"J Steroid Biochem Mol Biol"},{"key":"6587_CR54","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/cas.13532","volume":"109","author":"K Shi","year":"2018","unstructured":"Shi K, Wang Q, Su Y, Xuan X, Liu Y, Chen W, Qian Y, Lash GE.\u00a0(2018) Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma. Cancer Sci 109:1032\u20131043","journal-title":"Cancer Sci"},{"issue":"1","key":"6587_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/cancers12010124","volume":"12","author":"A Valle-Mendiola","year":"2020","unstructured":"Valle-Mendiola A, Soto-Cruz I (2020) Energy metabolism in cancer: the roles of STAT3 and STAT5 in the regulation of metabolism-related genes. Cancers (Basel) 12(1):124","journal-title":"Cancers (Basel)"},{"issue":"21","key":"6587_CR56","doi-asserted-by":"publisher","first-page":"10749","DOI":"10.1021\/ac502792u","volume":"86","author":"M Andr\u00e9","year":"2014","unstructured":"Andr\u00e9 M, Dumez JN, Rezig L, Shintu L, Piotto M, Caldarelli S (2014) Complete protocol for slow-spinning high-resolution magic-angle spinning NMR analysis of fragile tissues. Anal Chem 86(21):10749\u201310754","journal-title":"Anal Chem"},{"key":"6587_CR57","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00404-019-05299-2","volume":"300","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, D\u2019Alessandro P, Arduino B, de Placido G, Mascolo M, Insabato L, Zullo F (2019) Significant risk of occult cancer in complex non-atypical endometrial hyperplasia. Arch Gynecol Obstet 300:1147\u20131154. https:\/\/doi.org\/10.1007\/s00404-019-05299-2","journal-title":"Arch Gynecol Obstet"},{"key":"6587_CR58","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/aogs.13587","volume":"98","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, De Placido G, Zullo F (2019) Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand 98:1086\u20131099. https:\/\/doi.org\/10.1111\/aogs.13587","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6587_CR59","first-page":"305","volume":"8","author":"RE Boh\u00eel\u021bea","year":"2015","unstructured":"Boh\u00eel\u021bea RE, Anc\u0103r V, Cirstoiu MM, R\u0103doi V, Boh\u00eel\u021bea LC, Furtunescu F (2015) Project for the National program of early diagnosis of endometrial cancer part I. J Med Life 8:305\u2013314","journal-title":"J Med Life"},{"key":"6587_CR60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/17425255.2016.1238460","volume":"12","author":"VJ Hwang","year":"2016","unstructured":"Hwang VJ, Weiss RH (2016) Metabolomic profiling for early cancer detection: current status and future prospects. Expert Opin Drug Metab Toxicol 12:1263\u20131265. https:\/\/doi.org\/10.1080\/17425255.2016.1238460","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"6587_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.trac.2004.11.021","volume":"24","author":"WB Dunn","year":"2005","unstructured":"Dunn WB, Ellis DI (2005) Metabolomics: current analytical platforms and methodologies. TrAC Trends Anal Chem 24:285\u2013294. https:\/\/doi.org\/10.1016\/j.trac.2004.11.021","journal-title":"TrAC Trends Anal Chem"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06587-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T12:07:39Z","timestamp":1667650059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06587-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6587"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06587-0","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review boards approved the study (Approval no: 19\u2013119). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki. Declaration and informed consent forms had been obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}